Nevro Corp
NYSE:NVRO
Balance Sheet
Balance Sheet Decomposition
Nevro Corp
Nevro Corp
Balance Sheet
Nevro Corp
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
87
|
41
|
43
|
51
|
65
|
45
|
35
|
120
|
104
|
95
|
|
| Cash Equivalents |
87
|
41
|
43
|
51
|
65
|
45
|
35
|
120
|
104
|
95
|
|
| Short-Term Investments |
107
|
235
|
227
|
213
|
172
|
543
|
327
|
254
|
219
|
198
|
|
| Total Receivables |
23
|
53
|
67
|
81
|
83
|
78
|
71
|
79
|
79
|
72
|
|
| Accounts Receivables |
23
|
53
|
67
|
81
|
83
|
78
|
71
|
79
|
79
|
72
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
62
|
85
|
98
|
92
|
92
|
83
|
94
|
100
|
119
|
103
|
|
| Other Current Assets |
4
|
6
|
7
|
7
|
10
|
4
|
5
|
10
|
10
|
8
|
|
| Total Current Assets |
283
|
420
|
441
|
444
|
422
|
753
|
531
|
563
|
531
|
476
|
|
| PP&E Net |
6
|
7
|
9
|
13
|
33
|
32
|
38
|
36
|
34
|
48
|
|
| PP&E Gross |
6
|
7
|
9
|
13
|
33
|
32
|
38
|
36
|
34
|
48
|
|
| Accumulated Depreciation |
1
|
2
|
5
|
9
|
13
|
18
|
23
|
29
|
36
|
43
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
24
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
0
|
|
| Other Long-Term Assets |
3
|
3
|
4
|
7
|
14
|
5
|
5
|
4
|
6
|
6
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
0
|
|
| Total Assets |
291
N/A
|
431
+48%
|
454
+5%
|
463
+2%
|
470
+1%
|
789
+68%
|
575
-27%
|
602
+5%
|
636
+6%
|
554
-13%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
22
|
16
|
19
|
24
|
16
|
23
|
32
|
27
|
23
|
24
|
|
| Accrued Liabilities |
12
|
24
|
37
|
36
|
52
|
46
|
49
|
51
|
51
|
39
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
169
|
0
|
0
|
0
|
38
|
|
| Other Current Liabilities |
2
|
2
|
3
|
3
|
3
|
1
|
1
|
2
|
10
|
2
|
|
| Total Current Liabilities |
36
|
42
|
58
|
62
|
71
|
239
|
82
|
79
|
83
|
103
|
|
| Long-Term Debt |
20
|
138
|
145
|
152
|
160
|
142
|
151
|
187
|
211
|
188
|
|
| Other Liabilities |
1
|
1
|
2
|
3
|
22
|
20
|
37
|
13
|
48
|
32
|
|
| Total Liabilities |
57
N/A
|
182
+221%
|
205
+13%
|
218
+6%
|
253
+16%
|
401
+58%
|
271
-32%
|
279
+3%
|
343
+23%
|
323
-6%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
189
|
221
|
258
|
306
|
410
|
493
|
624
|
607
|
699
|
813
|
|
| Additional Paid In Capital |
424
|
471
|
508
|
553
|
626
|
881
|
928
|
934
|
993
|
1 045
|
|
| Other Equity |
0
|
1
|
1
|
1
|
0
|
1
|
0
|
3
|
0
|
1
|
|
| Total Equity |
235
N/A
|
249
+6%
|
249
+0%
|
246
-1%
|
216
-12%
|
389
+80%
|
304
-22%
|
324
+7%
|
293
-9%
|
231
-21%
|
|
| Total Liabilities & Equity |
291
N/A
|
431
+48%
|
454
+5%
|
463
+2%
|
470
+1%
|
789
+68%
|
575
-27%
|
602
+5%
|
636
+6%
|
554
-13%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
28
|
29
|
30
|
30
|
32
|
35
|
36
|
36
|
36
|
38
|
|